{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T15:35:22Z","timestamp":1793720122819,"version":"4.6.1"},"reference-count":56,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2019.20843","type":"journal-article","created":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T16:31:08Z","timestamp":1581093068000},"page":"e1920843","source":"Crossref","is-referenced-by-count":78,"title":["Differences in Availability and Use of Medications for Opioid Use Disorder in Residential Treatment Settings in the United States"],"prefix":"10.1001","volume":"3","author":[{"given":"Andrew S.","family":"Huhn","sequence":"first","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland"},{"name":"Ashley Addiction Treatment, Havre de Grace, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Gregory","family":"Hobelmann","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland"},{"name":"Ashley Addiction Treatment, Havre de Grace, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin C.","family":"Strickland","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George A.","family":"Oyler","sequence":"additional","affiliation":[{"name":"Ashley Addiction Treatment, Havre de Grace, Maryland"},{"name":"Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia L.","family":"Bergeria","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Umbricht","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly E.","family":"Dunn","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2020,2,7]]},"reference":[{"issue":"2","key":"zoi190783r1","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1001\/jama.2018.8826","article-title":"Helping to end addiction over the long-term: the research plan for the NIH HEAL initiative.","volume":"320","author":"Collins","year":"2018","journal-title":"JAMA"},{"issue":"22","key":"zoi190783r2","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1056\/NEJMp1402780","article-title":"Medication-assisted therapies: tackling the opioid-overdose epidemic.","volume":"370","author":"Volkow","year":"2014","journal-title":"N Engl J Med"},{"issue":"11","key":"zoi190783r3","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1097\/00005650-200111000-00003","article-title":"Access to inpatient or residential substance abuse treatment among homeless adults with alcohol or other drug use disorders.","volume":"39","author":"Wenzel","year":"2001","journal-title":"Med Care"},{"issue":"1 Pt 1","key":"zoi190783r4","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/hesr.2003.38.issue-1p1","article-title":"Effectiveness and cost-effectiveness of four treatment modalities for substance disorders: a propensity score analysis.","volume":"38","author":"Mojtabai","year":"2003","journal-title":"Health Serv Res"},{"issue":"10","key":"zoi190783r5","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1046\/j.1360-0443.2002.00227.x","article-title":"Factors associated with abstinence, lapse or relapse to heroin use after residential treatment: protective effect of coping responses.","volume":"97","author":"Gossop","year":"2002","journal-title":"Addiction"},{"issue":"1","key":"zoi190783r6","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/add.2007.103.issue-1","article-title":"Attendance at Narcotics Anonymous and Alcoholics Anonymous meetings, frequency of attendance and substance use outcomes after residential treatment for drug dependence: a 5-year follow-up study.","volume":"103","author":"Gossop","year":"2008","journal-title":"Addiction"},{"issue":"1","key":"zoi190783r7","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jsat.2007.01.011","article-title":"A systematic review of psychosocial research on psychosocial interventions for people with co-occurring severe mental and substance use disorders.","volume":"34","author":"Drake","year":"2008","journal-title":"J Subst Abuse Treat"},{"issue":"4","key":"zoi190783r9","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3109\/10826088409057189","article-title":"Paraprofessional versus professional drug counselors: the progress of clients in treatment.","volume":"19","author":"Aiken","year":"1984","journal-title":"Int J Addict"},{"issue":"1","key":"zoi190783r10","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12889-019-6499-5","article-title":"Timely linkage of individuals to substance use disorder treatment: development, implementation, and evaluation of FindHelpNowKY.org.","volume":"19","author":"Bunn","year":"2019","journal-title":"BMC Public Health"},{"issue":"4","key":"zoi190783r11","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1097\/ADM.0000000000000310","article-title":"Vermont hub-and-spoke model of care for opioid use disorder: development, implementation, and impact.","volume":"11","author":"Brooklyn","year":"2017","journal-title":"J Addict Med"},{"issue":"8","key":"zoi190783r12","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.2105\/AJPH.2015.302664","article-title":"National and state treatment need and capacity for opioid agonist medication-assisted treatment.","volume":"105","author":"Jones","year":"2015","journal-title":"Am J Public Health"},{"key":"zoi190783r13","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.drugalcdep.2016.10.015","article-title":"Treatment utilization among persons with opioid use disorder in the United States.","volume":"169","author":"Wu","year":"2016","journal-title":"Drug Alcohol Depend"},{"issue":"10","key":"zoi190783r14","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1001\/jama.283.10.1303","article-title":"Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial.","volume":"283","author":"Sees","year":"2000","journal-title":"JAMA"},{"issue":"2","key":"zoi190783r15","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1016\/S0376-8716(03)00059-0","article-title":"Clinical efficacy of buprenorphine: comparisons to methadone and placebo.","volume":"70","author":"Ling","year":"2003","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"zoi190783r16","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1001\/jama.2016.9382","article-title":"Effect of buprenorphine implants on illicit opioid use among abstinent adults with opioid dependence treated with sublingual buprenorphine: a randomized clinical trial.","volume":"316","author":"Rosenthal","year":"2016","journal-title":"JAMA"},{"issue":"10173","key":"zoi190783r17","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/S0140-6736(18)32259-1","article-title":"Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.","volume":"393","author":"Haight","year":"2019","journal-title":"Lancet"},{"issue":"9776","key":"zoi190783r18","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1016\/S0140-6736(11)60358-9","article-title":"Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial.","volume":"377","author":"Krupitsky","year":"2011","journal-title":"Lancet"},{"key":"zoi190783r19","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.drugalcdep.2017.08.019","article-title":"The relationship between treatment accessibility and preference amongst out-of-treatment individuals who engage in non-medical prescription opioid use.","volume":"180","author":"Huhn","year":"2017","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"zoi190783r20","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1526-4637.2004.04044.x","article-title":"Dear DEA.","volume":"5","author":"Heit","year":"2004","journal-title":"Pain Med"},{"issue":"9","key":"zoi190783r21","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1007\/s11606-007-0264-7","article-title":"Barriers to obtaining waivers to prescribe buprenorphine for opioid addiction treatment among HIV physicians.","volume":"22","author":"Cunningham","year":"2007","journal-title":"J Gen Intern Med"},{"issue":"5","key":"zoi190783r22","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1176\/appi.ajp.2016.16050548","article-title":"Long-acting injectable naltrexone induction: a randomized trial of outpatient opioid detoxification with naltrexone versus buprenorphine.","volume":"174","author":"Sullivan","year":"2017","journal-title":"Am J Psychiatry"},{"issue":"14","key":"zoi190783r23","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1001\/jama.2014.2147","article-title":"Confronting the stigma of opioid use disorder\u2014and its treatment.","volume":"311","author":"Olsen","year":"2014","journal-title":"JAMA"},{"key":"zoi190783r24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsat.2017.04.005","article-title":"Why aren\u2019t physicians prescribing more buprenorphine?","volume":"78","author":"Huhn","year":"2017","journal-title":"J Subst Abuse Treat"},{"issue":"2","key":"zoi190783r25","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1080\/08897077.2018.1452327","article-title":"Medications for opioid use disorder in the Department of Veterans Affairs (VA) health care system: historical perspective, lessons learned, and next steps.","volume":"39","author":"Wyse","year":"2018","journal-title":"Subst Abus"},{"issue":"6","key":"zoi190783r26","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1377\/hlthaff.2014.1205","article-title":"Growth in buprenorphine waivers for physicians increased potential access to opioid agonist treatment, 2002\u201311.","volume":"34","author":"Dick","year":"2015","journal-title":"Health Aff (Millwood)"},{"issue":"14","key":"zoi190783r27","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1001\/jama.2015.10345","article-title":"Changes in substance abuse treatment use among individuals with opioid use disorders in the United States, 2004-2013.","volume":"314","author":"Saloner","year":"2015","journal-title":"JAMA"},{"issue":"2","key":"zoi190783r28","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1080\/10826084.2017.1363238","article-title":"Barriers to medications for addiction treatment: how stigma kills.","volume":"53","author":"Wakeman","year":"2018","journal-title":"Subst Use Misuse"},{"key":"zoi190783r29","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.drugalcdep.2015.09.032","article-title":"States\u2019 implementation of the Affordable Care Act and the supply of physicians waivered to prescribe buprenorphine for opioid dependence.","volume":"157","author":"Knudsen","year":"2015","journal-title":"Drug Alcohol Depend"},{"issue":"12","key":"zoi190783r30","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1377\/hlthaff.2016.0623","article-title":"Survey highlights differences in Medicaid coverage for substance use treatment and opioid use disorder medications.","volume":"35","author":"Grogan","year":"2016","journal-title":"Health Aff (Millwood)"},{"issue":"1","key":"zoi190783r31","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/1475-6773.12686","article-title":"Geographic disparities in availability of opioid use disorder treatment for Medicaid enrollees.","volume":"53","author":"Abraham","year":"2018","journal-title":"Health Serv Res"},{"issue":"4","key":"zoi190783r32","doi-asserted-by":"publisher","first-page":"644","DOI":"10.15288\/jsad.2015.76.644","article-title":"The supply of physicians waivered to prescribe buprenorphine for opioid use disorders in the United States: a state-level analysis.","volume":"76","author":"Knudsen","year":"2015","journal-title":"J Stud Alcohol Drugs"},{"issue":"1","key":"zoi190783r33","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1377\/hlthaff.2018.05162","article-title":"Medication treatment for opioid use disorders in substance use treatment facilities.","volume":"38","author":"Mojtabai","year":"2019","journal-title":"Health Aff (Millwood)"},{"issue":"3","key":"zoi190783r34","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1080\/08897077.2016.1187241","article-title":"Medication-assisted treatment for opioid dependence in Twelve Step\u2013oriented residential rehabilitation settings.","volume":"37","author":"Galanter","year":"2016","journal-title":"Subst Abus"},{"issue":"5","key":"zoi190783r35","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s10597-017-0218-4","article-title":"Oxford House residents\u2019 attitudes toward medication assisted treatment use in fellow residents.","volume":"54","author":"Majer","year":"2018","journal-title":"Community Ment Health J"},{"issue":"4","key":"zoi190783r36","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1080\/09595230412331324590","article-title":"A review of research on residential programs for people with severe mental illness and co-occurring substance use disorders.","volume":"23","author":"Brunette","year":"2004","journal-title":"Drug Alcohol Rev"},{"issue":"4","key":"zoi190783r37","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1097\/ADM.0000000000000498","article-title":"Recovery goals and long-term treatment preference in persons who engage in nonmedical opioid use.","volume":"13","author":"Hay","year":"2019","journal-title":"J Addict Med"},{"issue":"4","key":"zoi190783r45","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1097\/ADM.0000000000000408","article-title":"Applying American Society of Addiction Medicine performance measures in commercial health insurance and services data.","volume":"12","author":"Thomas","year":"2018","journal-title":"J Addict Med"},{"issue":"1","key":"zoi190783r46","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2105\/AJPH.2016.303558","article-title":"The Affordable Care Act transformation of substance use disorder treatment.","volume":"107","author":"Abraham","year":"2017","journal-title":"Am J Public Health"},{"key":"zoi190783r47","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jsat.2019.04.001","article-title":"The payer\u2019s role in addressing the opioid epidemic: it\u2019s more than money.","volume":"101","author":"Molfenter","year":"2019","journal-title":"J Subst Abuse Treat"},{"issue":"8","key":"zoi190783r48","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1377\/hlthaff.2010.0532","article-title":"The evidence doesn\u2019t justify steps by state Medicaid programs to restrict opioid addiction treatment with buprenorphine.","volume":"30","author":"Clark","year":"2011","journal-title":"Health Aff (Millwood)"},{"issue":"2","key":"zoi190783r49","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1001\/jama.2008.976","article-title":"Treating drug abuse and addiction in the criminal justice system: improving public health and safety.","volume":"301","author":"Chandler","year":"2009","journal-title":"JAMA"},{"key":"zoi190783r50","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.drugalcdep.2018.10.002","article-title":"A hidden aspect of the U.S. opioid crisis: rise in first-time treatment admissions for older adults with opioid use disorder.","volume":"193","author":"Huhn","year":"2018","journal-title":"Drug Alcohol Depend"},{"key":"zoi190783r51","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.drugalcdep.2017.10.007","article-title":"Treatment for opioid use and outcomes in older adults: a systematic literature review.","volume":"182","author":"Carew","year":"2018","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"zoi190783r52","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/ajad.12921","article-title":"Sex-based differences in treatment outcomes for persons with opioid use disorder.","volume":"28","author":"Huhn","year":"2019","journal-title":"Am J Addict"},{"issue":"5","key":"zoi190783r53","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.amepre.2018.01.040","article-title":"Factors associated with county-level differences in US drug-related mortality rates.","volume":"54","author":"Monnat","year":"2018","journal-title":"Am J Prev Med"},{"issue":"6","key":"zoi190783r54","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.amepre.2017.06.009","article-title":"Geographic variation in opioid and heroin involved drug poisoning mortality rates.","volume":"53","author":"Ruhm","year":"2017","journal-title":"Am J Prev Med"},{"issue":"1","key":"zoi190783r55","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.amepre.2018.03.014","article-title":"Drug mortality and lost life years among US midlife adults, 1999\u20132015.","volume":"55","author":"Ruhm","year":"2018","journal-title":"Am J Prev Med"},{"issue":"4","key":"zoi190783r56","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1007\/s11524-010-9438-4","article-title":"Improved HIV and substance abuse treatment outcomes for released HIV-infected prisoners: the impact of buprenorphine treatment.","volume":"87","author":"Springer","year":"2010","journal-title":"J Urban Health"},{"key":"zoi190783r8","volume-title":"Slaying the Dragon: The History of Addiction Treatment and Recovery in America","author":"White","year":"1998"},{"key":"zoi190783r38","unstructured":"LurieJ. \u201cMom, when they look at me, they see dollar signs.\u201d https:\/\/www.motherjones.com\/crime-justice\/2019\/02\/opioid-epidemic-rehab-recruiters\/. Accessed December 19, 2019."},{"key":"zoi190783r39","unstructured":"Substance Abuse and Mental Health Services Administration. National survey of substance abuse treatment services (N-SSATS): 2017, data on substance abuse treatment facilities. https:\/\/www.samhsa.gov\/data\/report\/national-survey-substance-abuse-treatment-services-n-ssats-2017-data-substance-abuse. Accessed January 10, 2019."},{"key":"zoi190783r40","unstructured":"Substance Abuse and Mental Health Data Archive. Treatment Episode Data Set: Admissions. https:\/\/www.datafiles.samhsa.gov\/study-series\/treatment-episode-data-set-admissions-teds-nid13518. Accessed December 15, 2018."},{"key":"zoi190783r41","unstructured":"National Institute on Drug Abuse. Opioid summaries by state. https:\/\/www.drugabuse.gov\/drugs-abuse\/opioids\/opioid-summaries-by-state. Accessed July 7, 2019."},{"key":"zoi190783r42","unstructured":"US Centers for Disease Control and Prevention. CDC Wonder. https:\/\/wonder.cdc.gov\/. Accessed July 10, 2019."},{"key":"zoi190783r43","unstructured":"Kaiser Family Foundation. Medicaid\u2019s role in addressing the opioid epidemic. https:\/\/www.kff.org\/infographic\/medicaids-role-in-addressing-opioid-epidemic\/. Accessed July 10, 2019."},{"key":"zoi190783r44","unstructured":"Clemans-CopeL, LynchV, EpsteinM, KenneyGM. Medicaid coverage of effective treatment for opioid use disorder. https:\/\/www.urban.org\/sites\/default\/files\/publication\/90461\/2001287_medicaid_coverage_of_effective_treatment_for_opioid_use_disorder.pdf. Accessed January 10, 2019."}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2760443\/huhn_2020_oi_190783.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T16:31:12Z","timestamp":1581093072000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2760443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,7]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2,5]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.20843","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,7]]}}}